A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck

NCT07346196 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma

Interventions

DRUG: Cemiplimab
DRUG: Fianlimab
DRUG: Carboplatin
DRUG: Paclitaxel
RADIATION: Radiation

Sponsor

University of Chicago